Skip to Main Content

Paper Details

Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma.
Nat Med
54
2021
Author NameAffiliation
Brian J HaasBroad Institute of Harvard and MIT
Brian J HaasBroad Institute of Harvard and MIT
Brian J HaasBroad Institute of Harvard and MIT
Brian J HaasBroad Institute of Harvard and MIT
Gaylor BoulayBroad Institute of Harvard and MIT
Gaylor BoulayDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School
Michael S CuocoBroad Institute of Harvard and MIT
Michael S CuocoUniversity of California
Nikhil WagleBroad Institute of Harvard and MIT
Nikhil WagleDana-Farber Cancer Institute and Harvard Medical School
Nikhil WagleBroad Institute of Harvard and MIT
Nikhil WagleDana-Farber Cancer Institute and Harvard Medical School
Peter K SorgerHarvard Medical School
Alex B HaynesMassachusetts General Hospital
Orit Rozenblatt-RosenBroad Institute of Harvard and MIT
Orit Rozenblatt-Rosen
Orit Rozenblatt-RosenBroad Institute of Harvard and MIT
Mario L Suv??Broad Institute of Harvard and MIT
Mario L Suv??Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School
Mario L Suv??Broad Institute of Harvard and MIT
Mario L Suv??Broad Institute of Harvard and MIT
Mario L Suv??Broad Institute of Harvard and MIT
Mario L Suv??Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School
Aviv RegevBroad Institute of Harvard and MIT
Aviv RegevBroad Institute of Harvard and MIT
Aviv RegevHoward Hughes Medical Institute, Koch Institute for Integrative Cancer Research
Aviv Regev
Aviv RegevBroad Institute of Harvard and MIT
Aviv RegevBroad Institute of Harvard and MIT
Aviv RegevHoward Hughes Medical Institute, Koch Institute for Integrative Cancer Research
Aviv Regev
  • 1 - 31

Datasets

Release 1.2